MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference
MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) brings a pharmaceutical perspective to the cannabis industry, working to internationally recognized pharma-quality standards which result in products that are pure, trusted and precisely doseable for patients and end consumers. MediPharm Labs specializes in the creation and formulation of bulk active pharmaceutical ingredients (API’s) as well as the sale of white-labeled formulated finished products to a wide range of corporate partners in addition to its own proprietary, MediPharm Labs-branded products. MediPharm is currently working on the production of 60 different products and supplying API’s to clients in Australia, Europe, North America as well as…

















